Haemonetics (HAE) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Haemonetics (HAE) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 2, 2023 (11:49)

Sector: Healthcare

The share price of Haemonetics Corporation (HAE) now

What analysts predict: $106.14
52-week High/Low: $95.26 / $72.26

50/200 Day Moving Average: $87.91 / $85.55

This figure corresponds to the Average Price over the previous 50/200 days. For Haemonetics stocks, the 50-day moving average is the resistance level today.

For Haemonetics stocks, the 200-day moving average is the resistance level today.

Are you interested in Haemonetics Corporation stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Haemonetics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Haemonetics share be worth in 2023 - 2027?

When should I take profit in Haemonetics stock? When should I record a loss on Haemonetics stock? What are analysts' forecasts for Haemonetics stock? What is the future of Haemonetics stock? We forecast Haemonetics stock performance using neural networks based on historical data on Haemonetics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Haemonetics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Haemonetics shares. This happens once a day.




Historical and forecast chart of Haemonetics stock

The chart below shows the historical price of Haemonetics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Haemonetics stock price can be found in the table below.

Long-term forecasts by years.

Haemonetics Corporation is a medical company offering hematology products and solutions. It operates through three segments: Plasma, Blood Center and Hospital. The company offers automated plasma collection devices, related disposable products and software, including NexSys PCS and PCS2 plasmapheresis equipment, as well as related disposable and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations and supply chain; and the NexLynk DMS Donor Management System.

Haemonetics daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 04 86.80 86.24 87.45 1.40
Dec 05 86.17 85.17 86.69 1.79
Dec 06 86.84 85.20 88.38 3.72
Dec 07 85.23 83.57 86.42 3.40
Dec 08 85.33 83.69 86.27 3.07
Dec 09 85.67 83.69 86.30 3.12
Dec 10 86.87 85.20 88.60 3.99
Dec 11 86.82 85.15 87.50 2.75
Dec 12 84.73 83.45 85.61 2.59
Dec 13 83.74 82.24 85.49 3.96
Dec 14 82.65 82.08 83.20 1.37
Dec 15 81.55 80.77 83.18 2.99
Dec 16 82.40 81.75 82.90 1.40
Dec 17 81.71 80.00 83.34 4.18
Dec 18 84.03 82.86 85.93 3.71
Dec 19 83.40 82.04 84.24 2.68
Dec 20 83.37 81.65 83.88 2.72
Dec 21 84.19 82.90 85.54 3.18
Dec 22 82.92 81.05 84.01 3.65
Dec 23 80.88 80.32 81.58 1.58
Dec 24 81.93 80.22 83.46 4.03
Dec 25 82.32 80.64 83.89 4.03
Dec 26 82.08 81.31 82.98 2.05
Dec 27 83.43 81.91 84.96 3.72
Dec 28 83.29 81.60 84.50 3.55
Dec 29 84.23 83.72 85.35 1.95
Dec 30 82.54 82.07 84.27 2.68
Dec 31 83.07 82.06 84.49 2.97
Jan 01 81.29 79.90 82.66 3.45
Jan 02 82.37 81.13 82.90 2.18

Haemonetics Daily Price Targets


Haemonetics Stock Forecast 12-04-2023.

Forecast target price for 12-04-2023: $86.80.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 1.382%.
Pessimistic target level: 86.24
Optimistic target level: 87.45

Haemonetics Stock Forecast 12-05-2023.

Forecast target price for 12-05-2023: $86.17.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 1.758%.
Pessimistic target level: 85.17
Optimistic target level: 86.69

Haemonetics Stock Forecast 12-06-2023.

Forecast target price for 12-06-2023: $86.84.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.590%.
Pessimistic target level: 85.20
Optimistic target level: 88.38

Haemonetics Stock Forecast 12-07-2023.

Forecast target price for 12-07-2023: $85.23.
Negative dynamics for Haemonetics shares will prevail with possible volatility of 3.289%.
Pessimistic target level: 83.57
Optimistic target level: 86.42

Haemonetics Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $85.33.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 2.983%.
Pessimistic target level: 83.69
Optimistic target level: 86.27

Haemonetics Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $85.67.
Positive dynamics for Haemonetics shares will prevail with possible volatility of 3.023%.
Pessimistic target level: 83.69
Optimistic target level: 86.30

HAE (HAE) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Dec. 78.48 75.89 81.85 7.29

Haemonetics forecast for this year


Haemonetics Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $78.4792. Pessimistic: $75.89. Optimistic: $81.85



Haemonetics (HAE) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 75.34 71.87 79.48 9.57
Feb 76.17 70.99 79.52 10.73
Mar 78.68 76.16 82.62 7.81
Apr 79.08 74.01 82.79 10.60
May 80.82 77.66 84.53 8.13
Jun 85.42 80.81 92.00 12.16
Jul 85.68 79.17 92.19 14.13
Aug 83.79 79.52 87.73 9.36
Sep 83.88 79.93 88.91 10.09
Oct 82.79 79.31 86.10 7.88
Nov 86.43 84.53 91.10 7.21
Dec 92.91 89.85 97.46 7.82

Haemonetics (HAE) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 94.03 88.01 97.22 9.48
Mar 95.44 89.81 99.16 9.43
Mar 96.96 89.98 102.88 12.54
Apr 104.72 99.69 111.32 10.44
May 108.60 105.34 117.28 10.18
Jun 108.49 105.23 110.87 5.09
Jul 101.65 96.16 105.72 9.04
Aug 103.89 98.90 107.84 8.28
Sep 107.21 100.24 112.79 11.12
Oct 112.15 106.65 115.62 7.76
Nov 112.03 105.65 116.85 9.59
Dec 112.48 107.19 117.77 8.98

Haemonetics (HAE) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 108.99 101.58 113.35 10.39
Mar 112.92 105.58 115.85 8.87
Mar 114.39 107.41 119.76 10.32
Apr 119.99 110.99 124.43 10.80
May 115.19 110.47 121.07 8.75
Jun 114.39 108.89 119.07 8.55
Jul 111.07 102.96 118.40 13.04
Aug 106.18 102.78 113.72 9.62
Sep 116.69 108.17 123.93 12.71
Oct 118.79 112.26 121.29 7.44
Nov 117.49 108.09 120.42 10.24
Dec 114.20 108.03 119.11 9.30

Haemonetics (HAE) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 123.90 115.23 130.97 12.02
Mar 123.28 118.23 130.93 9.70
Mar 125.50 118.48 132.66 10.69
Apr 121.99 119.55 128.58 7.02
May 120.89 111.34 128.14 13.11
Jun 122.70 113.99 125.65 9.28
Jul 123.93 115.63 133.23 13.21
Aug 132.98 128.86 137.23 6.10
Sep 135.24 124.42 141.19 11.88
Oct 145.65 138.52 157.01 11.78
Nov 158.18 150.90 169.41 10.92
Dec 165.30 154.55 170.09 9.14

Haemonetics information and performance

Haemonetics Address

125 SUMMER STREET, BOSTON, MA, US

Market Capitalization: 4 157 841 000 $

Market capitalization of the Haemonetics Corporation is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of HAE shares in the company outstanding by the market price of one share.

EBITDA: 288 618 000 $

EBITDA of Haemonetics is earnings before interest, income tax and depreciation of assets.

PE Ratio: 32.91

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 2.151

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0319

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.49

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.25
Quarterly Revenue Growth YOY: 0.07
Trailing PE: 32.91

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 25.45

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.333

Enterprise Value (EV) /Revenue

EV To EBITDA: 20.65

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 50742000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.